[Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
D000962:Antimalarials / Q000009:adverse effects; D002738:Chloroquine / Q000009:adverse effects*; D003318:Corneal Opacity / Q000139:chemically induced / Q000453:epidemiology / Q000534:rehabilitation; D004361:Drug Tolerance; D004596:Electroretinography; D005128:Eye Diseases / Q000139:chemically induced*; D006886:Hydroxychloroquine / Q000009:adverse effects*; D009887:Ophthalmoscopy; D012160:Retina / Q000187:drug effects; D012173:Retinitis / Q000175:diagnosis; D012607:Scotoma / Q000139:chemically induced; D013223:Statistics as Topic; D014792:Visual Acuity / Q000187:drug effects; D014794:Visual Fields / Q000187:drug effects
D000962:Antimalarials; D006886:Hydroxychloroquine; D002738:Chloroquine
La surveillance oculaire au cours des traitements prolongés par les antimalariques de synthèse. Résultats chez 237 malades suivis en moyenne pendant 4 ans.